Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
Cue Biopharma, Inc. (CUE)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/25/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/19/2023 |
3
| Levisetti Matteo (Chief Medical Officer) has filed a Form 3 on Cue Biopharma, Inc. |
01/04/2022 |
3
| NASSHORN PATRICIA (Chief Business Officer) has filed a Form 3 on Cue Biopharma, Inc. |
09/18/2020 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on Cue Biopharma, Inc. |
10/07/2019 |
3
| Fletcher Aaron G.L. (Director) has filed a Form 3 on Cue Biopharma, Inc. |
08/02/2018 |
3
| Mancilla Bethany (SVP and Chief Business Officer) has filed a Form 3 on Cue Biopharma, Inc. |
08/02/2018 |
3
| Morich Frank (Director) has filed a Form 3 on Cue Biopharma, Inc. |
06/27/2018 |
3
| DRISCOLL FREDERICK W (Director) has filed a Form 3 on Cue Biopharma, Inc. |
05/16/2018 |
3
| Suri Anish (Chief Scientific Officer) has filed a Form 3 on Cue Biopharma, Inc. |
05/11/2018 |
3
| Millar Kerri-Ann (VP-Finance) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Simon Barry J. (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Seidel Ronald D. III (EVP, Head of R&D) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| SCHUMAN GARY ALAN (Interim CFO) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Pienta Kenneth (Chief Medical Officer) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| PASSERI DANIEL R (CEO and President) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| MCKNIGHT STEVEN L (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| MARLETT CHRISTOPHER A (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Kiener Peter A (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Gray Cameron (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 3 on Cue Biopharma, Inc. |
12/27/2017 |
3
| Chaparro Rodolfo (EVP, Head of Immunology) has filed a Form 3 on Cue Biopharma, Inc. |
|
|